GHK-Cu is a research peptide offered for laboratory and research use only
Perhaps you ran out of your supply, or you are curious if your body still needs that extra boost
Research models with baseline HbA1c above 6.0% or fasting glucose above 110 mg/dL should not initiate this protocol without continuous glucose monitoring, as MK-677 specifically has been shown to increase fasting glucose by 58 mg/dL and HbA1c by 0.30.5% even in metabolically healthy subjects
Online listings are worse, with no proof of sterility, storage, or origin
If it involves immune dysregulation, then immunomodulation deserves investigation
Most importantly, tirzepatide appears to restore the bodys hormonal signaling system rather than bypassing it like TRT does